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ABSTRACT
EFFECT OF GRAPE COMPONENTS ON PERIODONTAL DISEASE
Juili Shivde
November 20, 2018
Background: Half of the adult American population (47 %) are victims of periodontitis,
a chronic inflammatory disease which leads to destruction of the tissues supporting the
tooth. Periodontitis is initiated by periodontal pathogens and caused by excessive or
prolonged host mediated inflammation. Porphyromonas gingivalis is one important agent
implicated in the etiopathogenesis of chronic periodontitis. Pro-inflammatory cytokines
induced by periodontal pathogens can cause alveolar bone loss and periodontitis. Bone
loss is caused by the imbalance of bone formation and bone resorption. Osteoclasts are
major cells that cause bone resorption. Moreover, periodontal inflammation also leads to
bone resorption. Grapes are rich in several components like catechin and proanthocyanidins, which possess extensive biologic properties including inhibitory effects
on oral bacteria and the ability to suppress inflammation. Grape components may
intensely inhibit osteoclastogenesis by suppressing osteoclast differentiation and thus
may be beneficial in anti-inflammatory treatment accompanying bone destruction. Grapes
may thus prove as a promising natural therapeutic agent for periodontitis therapy. They
may exhibit their anti-inflammatory and immunomodulatory properties by suppressing
the activation of NF-κB signal transduction pathways (Lee, Kim et al. 2017) (Chu, Tang
et al. 2016). The focus of this study was to determine the effects of grape components on
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bacterial growth, inflammation, and osteoclastogenesis in vitro and gingival
inflammation and bone loss in vivo.

Hypothesis: We hypothesize that grape powder extract will inhibit P. gingivalis growth,
suppress pro-inflammatory cytokines and inhibit osteoclastogenesis in vitro. We also
hypothesize that grape powder inhibits gingival inflammation and prevents bone loss in a
murine model.
Methods: In vitro – the effect of grape powder extract on bacterial growth was tested by
inoculating P. gingivalis into 1.5 ml microcentrifuge tubes containing different
concentrations (0.0625, 0.125, 0.5 µg/ml) of grape powder extract and incubating the
tubes at 37°C for 24 h. Controls included no grape powder treatment. The bacterial
number was determined by plating on blood agar for CFU. 105 Murine RAW 264.7 cells
were treated with grape powder extract (50, 100, 200 µg/ml) or no grape powder extract
and stimulated with 1 µg/ml P. gingivalis LPS overnight and tested for the expression of
IL-6 by ELISA. Similarly, 105 THP1-Blue cells™ were treated with grape powder extract
(50, 100, 200 µg/ml) or no grape powder extract, stimulated with 10 µg/ml P. gingivalis
LPS overnight. Activity of NF-κB-inducible alkaline phosphatase in THP1-Blue cells™
was determined by colorimetric activation. 103 RAW 264.7 cells were stimulated with
100 ng/ml RANKL and treated with 200 µg/ml grape powder extract. The cells with no
grape powder extract treatment were used as controls. Seven days later, the cultures were
fixed and stained with TRAP for 15 mins, an osteoclast marker and the number of TRAP
positive cells were counted microscopically.
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In vivo- Grape powder was tested in a 7-day murine ligature-induced periodontitis model
where mice received a ligation around the second molar and also a baker model, where P.
gingivalis was orally infected and mice were kept for 2 months. The mice consumed a
grape powder or no grape powder diet. Maxillary gingival tissue was tested for mRNA
expression of pro-inflammatory and anti-inflammatory cytokines by Quantitative realtime PCR in the ligature model. Alveolar bone loss was determined by measuring the
CEJ-ABC distance in the baker model. The statistical analysis used was a two-tailed t
test. (GraphPad Prism Software, San Diego, CA, USA). Differences were considered
statistically significant at a P value of <0.05.

Results: There was a decrease in the number of oral bacteria (CFU) with increasing
concentration of grape powder extract. Thus, grape powder extract inhibited P. gingivalis
growth. RAW 264.7 cells stimulated with P. gingivalis only showed maximum levels of
IL-6 production. However, in the cells that received grape powder extract, a decrease in
the amount of IL-6 was noted. THP1-Blue cells™ stimulated with P. gingivalis LPS and
treated with grape powder extract showed reduction in the level of NF-κB activity. Cells
without RANKL stimulation and grape powder extract treatment showed no formation of
TRAP-positive cells. Cells treated with grape powder extract showed a significant
reduction in the number of TRAP positive cells. Thus, grape powder extract inhibited P.
gingivalis growth, osteoclastogenesis and P. gingivalis-induced pro-inflammatory
cytokine production in vitro. There was a reduction in the levels of pro-inflammatory
cytokines IL-6 and TNF-α after treatment with grape powder in ligature model mice.
However, there were no significant changes in the levels of IL-17, IL-1b, IL-10 and
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TGF-b. CEJ-ABC distance was also reduced which indicated bone loss in the baker
model. Overall, grape powder reduced gingival inflammation and bone loss in murine
models.

Conclusion and practical implications: Grape components or grape consumption can
be beneficial in the prevention or treatment of periodontal disease. Grape components can
be useful for further development as a potential and safe therapeutic agent in periodontal
disease treatment.

Keywords:

Grape components, NF- κB pathway, periodontal diseases,

osteoclastogenesis, inflammation, alveolar bone loss, P. gingivalis
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CHAPTER 1. INTRODUCTION
1.1.

CHRONIC PERIODONTITIS

Epidemiological data in the USA derived from the National Health and Nutrition
Examination Survey (NHANES) stated that 47 % of adults had chronic periodontitis
which represented 64.7 million of the adult American population. 8.9 % of this lot had
severe periodontitis. (Eke, Dye et al. 2015). Some other studies reported that periodontal
disease affected 70% of the adult population aged 65 years and older (Papapanou, 2012).
According to WHO, 10-15 % of the population worldwide were victims of periodontitis
(Peterson and Ogawa, 2005). The prevailing paradigm reports that 538 million people
suffer from severe periodontal disease; and 276 million people worldwide exhibit total
tooth loss. The figures are expected to be on the rise as population grows and ages
(Kassebaum, Smith et al. 2017). Ironically, the treatment for periodontitis is very
expensive and majority of the victims fall under the low-income groups. They thus
refrain from seeking proper treatment (Petersen, Bourgeois et al. 2005). As of 2010, it
was reported that the cost of treatment for oral conditions including periodontitis were
estimated at US$298 billion worldwide, which accounted for around 4.6 % of the total
money spent on global health (Kassebaum, Smith et al. 2017).
Periodontitis is a microbial biofilm-induced, host-mediated inflammatory disease that
leads to clinical attachment loss (CAL). This attachment loss can be identified clinically
by a circumferential evaluation of the erupted teeth with the aid of a standardized
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instrument called the periodontal probe using cemento-enamel junction (CEJ) as a
landmark (Tonetti, Greenwell et al. 2018). Although the microbial biofilm is required but
not sufficient to cause disease, the host inflammatory response to the microbial challenge
is the key to periodontal destruction (Hajishengallis and Lamont 2012). Periodontitis
may impact systemic health (Kinane, Stathopoulou et al. 2017). The framework for
staging and grading of periodontitis has been classified as Stage 1 – Initial periodontitis,
Stage 2 – Moderate periodontitis, Stage 3 – Severe periodontitis with potential for
additional tooth loss, Stage 4 – Advanced periodontitis with extensive tooth loss and
potential for loss of dentition. This classification is based upon the disease severity and
complexity of management (Tonetti, Greenwell et al. 2018).
Periodontitis is one of the most common inflammatory diseases encountered in the oral
cavity (Zhou, Su et al. 2018). In 1998, the etiology of periodontitis was fueled by one
theory that specific organisms like Porphyromonas gingivalis, Treponema Denticola and
Tanerella Forsythia, popularly known as the “red complex”, were responsible for disease
progression. The complexes were established based on the results of multiple cluster and
community ordination analysis using DNA probes with the red complex exhibiting a
striking relation to periodontal pocket depth and bleeding on probing. (Socransky,
Haffajee et al. 1998). However, recently the etiology has shifted in favor of the
polymicrobial synergy and dysbiosis (the ‘PSD model’) (Hajishengallis and Lamont
2012). Dysbiosis or imbalance in the ecosystem of microorganisms further leads to
changes in the host-microbe crosstalk resulting in destructive inflammation and bone loss
typical of periodontal disease (Abusleme, Dupuy et al. 2013). Apart from being a major
factor causing loss of teeth, severe periodontitis has been linked to several systemic
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diseases like atherosclerosis, diabetes, rheumatoid arthritis and adverse pregnancy
outcomes like low birth weight (Kinane, Stathopoulou et al. 2017)(Madianos,
2013)(Khader, Dauod et al. 2006). Periodontal disease may expedite the progression of
these diseases due to increased overall inflammatory load on the body or pathogen
invasion into the circulation (Khader, Dauod et al. 2006).
1.2.

PATHOGENESIS OF CHRONIC PERIODONTITIS

1.2.1. PERIODONTAL DISEASE AND ORAL PATHOGENS
Microbes were discovered as early as the 1700’s by renowned scientist Antonie van
Leeuwenhoek (Gordon and Klaenhammer 2011). The microorganisms found in the oral
cavity have been termed as oral microflora, oral microbiota or oral microbiome which are
estimated to be around 600 different species with distinct subspecies (Dewhirst, Chen et
al. 2010). A balance between the resident microbiota and host immune response
maintains a state of homeostasis. However, imbalance between the same contributes to
oral diseases like caries or periodontal disease (Gao, Xu et al. 2018). Researchers believe
that some of the most prevalent periodontal pathogens encountered in the oral cavity are
Aggregatibacter

actinomycetemcomitans,

Fusobacterium

nucleatum,

Tannerella

forsythia (formerly Bacteroides forsythus), Porphyromonas gingivalis, Prevotella
intermedia and Treponema denticola (Aruni, Dou et al. 2015). The oral bacterial biofilm
was first described by James Eon Wiliams in 1897 as a gel-like mass of bacteria adhering
to the tooth surface (Cassai, Galvan et al. 2003). Periodontitis is one good example of a
biofilm-associated dental infection (Bergstrom 2006). The etiology of this biofilminduced disease has been associated with several theories - keystone pathogen, red
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complex, specific and non-specific microorganisms, polymicrobial synergy and dysbiosis
to name a few (Hajishengallis 2014).
1.2.2. P. gingivalis
P. gingivalis is a Gram-negative, anaerobic, rod-shaped bacteria forming black colonies
on blood agar. It has been identified by researchers as one of the causative factors in the
pathogenesis and the severity of periodontal disease (Geng, Liu et al. 2017). Although
reported as most prevalent by some studies in animal models, the keystone pathogen
theory postulates that P. gingivalis in low abundance induces chronic periodontitis by
remodeling the commensal bacterial community to promote a state of dysbiosis leading to
disease. In other words, this bacteria in relatively low numbers could interfere with the
organization of the existing symbiosis between the local oral bacteria which in turn
effects the innate immune response (Olsen, Lambris et al. 2017). It thus might be
implicated in the pathogenesis of periodontal disease since it was detected in 85.75 %
subgingival plaque of chronic periodontitis patients (How, Song et al. 2016). P. gingivalis
is particularly of interest to researchers due to its easy method of culture and ability to
alter genetic makeup (Hajishengallis and Lamont 2012).
P. gingivalis benefits from several companion species like Streptococcus gordonii in the
sub gingival plaque on its path to tissue destruction. It can efficiently modify the host
immune response and create an environment favorable to its continued persistence
(Hajishengallis, Liang et al. 2011). Keystone pathogen P.

gingivalis and accessory

pathogen S. gordonii interact to form communities and subsequent colonization of dental
plaque (Kuboniwa, Houser et al. 2017). Although the mechanistic of this interaction are
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not fully elucidated, it is believed that P. gingivalis binds to GAPDH and surface proteins
on the surface of S. gordonii which ultimately favor the formation of P. gingivalis
biofilms on the tooth surface (Maeda, Nagata et al. 2015).
P. gingivalis is known to produce a wide array of virulence factors that could cause tissue
destruction on their own or through other mediators, with inflammation as an outcome
(Hajishengallis and Lamont 2014). Virulence factors are integral molecules expressed by
an organism at various stages of its life cycle with capacity to damage the host, namely
enzymes, capsule, lipopolysaccharide, fimbriae etc. (How, Song et al. 2016).
Lipopolysaccharide (LPS) is a pathogen associated molecular pattern (PAMP) or more
recently identified as microbe-associated molecular pattern (MAMP) (Newman, Sundelin
et al. 2013) and also a major component of the gram-negative bacterial cell walls of
periodontal pathogen P. gingivalis (Darveau, Arbabi et al. 2002). It mediates the host
inflammatory response by stimulating Toll-like receptor 4 (TLR4) (Park and Lee 2013).
Lipid A component of LPS present in its outermost membrane is responsible for its
virulence properties. P. gingivalis LPS contains multiple forms of Lipid A (Darveau,
Pham et al. 2004). The chemical structure of P. gingivalis Lipid A was determined to be a
glucosamine beta-(1-6) disaccharide 1-monophosphate acylated by 3-hydroxy-15methylhexadecanoic acid and 3-hexadecanoyloxy-15-methylhexadecanoic acid at the 2and 2'-positions, respectively (Ogawa 1993). Host cells are highly specific and sensitive
to Lipid A which contributes to the inflammatory response of gingival tissues, thereby
creating a favorable environment for pathogens to sustain and ultimately cause
periodontal disease progression (Herath, Darveau et al. 2013). It also comprises the outer
leaflet of most other Gram-negative commensal bacteria like E.coli (Wang and Quinn
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2010). LPS exists as structurally different forms in different bacterial species depending
on fatty acid acyl chain composition and charge which may elucidate the mechanism by
which the host may recognize bacterial species. The variation of LPS in different strains
of P. gingivalis has been identified, however the basis for this variation still remains
controversial (Darveau, Arbabi et al. 2002). LPS has been chosen as our virulence factor
of interest due its stable nature and easy availability commercially.
1.3.

PERIODONTAL DISEASE AND INFLAMMATION

Roman scholar Celcus defines inflammation as a common physical condition in which
some part of the body exhibits rubor (redness), calor (heat), dolor (pain) and swelling
(tumor) (Ciaccia 2011). Recently, a fifth sign has also been defined which is function
laesa (loss of function). Periodontal disease begins with gingivitis, which is a localized
inflammatory response in the gingiva to harmful stimuli of oral bacteria. Ideally at this
stage, elimination of the supra gingival and sub gingival plague by resorting to
mechanical methods like scaling and root planning will allow the junctional epithelium
(tissue that connects the tooth to the bone) to grow and restore tissue health. If left
untreated, the gingivitis progresses to periodontitis. As suggested by the 2017 World
Workshop, a patient is said to have periodontitis if clinically, there is interdental CAL
identifiable at 2 or more than 2 non-adjacent teeth, OR buccal or oral CAL is 3 mm or
greater with pocket formation greater than 3 mm and identifiable at 2 or more teeth. Also,
the CAL may not have occurred as a result of any non-periodontal causes and is
detectable clinically (Tonetti, Greenwell et al. 2018). Although the microbial biofilm is
the prime initiator of periodontal disease, genetic and environmental factors play a major
role in its sustenance (Kinane, Stathopoulou et al. 2017).
6

Cytokines are small secreted proteins and regulators of host response to infection,
immune response, inflammation and trauma. Pro-inflammatory cytokines released by
activated macrophages up-regulate inflammatory reactions associated with tissue
destruction and disease progression. In contrast, anti-inflammatory cytokines control the
response of pro-inflammatory cytokines to attenuate the disease process (Zhang and An
2007).
Pro-inflammatory cytokines such as IL1-b, IL-6 and TNF-α promote the function of
osteoclasts through activation of nuclear factor kappa-B ligand (RANKL) (Di Benedetto,
Gigante et al. 2013) (Kato et al., 2014). These cytokines coincide with the loss of
attachment and bone resorption critical to periodontal disease. The tissue destruction is
simply the outcome of the immoderate production of these cytokines due to exaggerated
host immune response (Graves and Cochran 2003).
Interleukins are a group of cytokines produced by one leukocyte but act at a leukocyte
site different from their production (Zhang and An 2007). They have gained popularity
lately due to the investigation regarding their role in periodontal disease. Here is a brief
summary of pro-inflammatory cytokines implicated in the pathogenesis of periodontal
disease:
1.3.1. IL-1
IL-1 has an impressive range of biological functions including the ability to control genes
conducive to inflammation (Dinarello 1996). It exists as two subtypes IL-1α and IL-1β.
Studies conducted on mice have shown that in the absence of IL-1 there is an exaggerated
inflammatory response and higher chances of developing infection (Labow, Shuster et al.
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1997). Only recently, several researchers have demonstrated that IL-1 is produced in
higher levels at periodontal disease sites. Injection of IL-1 in a murine model showed
signs of inflammation and bone resorption classic of periodontal disease (Hanazawa,
Nakada et al. 1985, Jandinski, Stashenko et al. 1991) (Kinane, Winstanley et al. 1992)
(Koide, Suda et al. 1995). The cellular sources of IL-1 in periodontal disease include
monocytes/macrophages, leukocytes, fibroblasts (gingival and periodontal ligament),
epithelial cells and osteoblasts (Graves and Cochran 2003). It is also one amongst the
most potent bone resorbing agents (Bertolini, Nedwin et al. 1986).
1.3.2. IL-6
IL-6 is a pro-inflammatory multifunctional cytokine produced by various cell types like
B- lymphocytes, monocytes, macrophages, keratinocytes and fibroblasts (Irwin and
Myrillas 1998). It is released in response to bacterial products like lipopolysaccharides or
in conjunction with fellow cytokines IL-1β and TNF-α (Kishimoto 1989). IL-6 is a potent
inducer of osteoclast formation and has been proven to cause bone resorption alone and
in synergism with IL-1β when tested in a murine model (Ishimi, Miyaura et al. 1990). IL6 has been found in the Gingival Crevicular Fluid associated with periodontal disease
sites which supports the theory that there is a correlation between concentration of IL-6
and level of periodontal disease. Due to its overall osteoclast-inducing nature, it is not
surprising for IL-6 to be implicated in pathological bone conditions like Rheumatoid
arthritis, Paget’s disease and Gorham-stout disease (Irwin and Myrillas 1998).

8

1.3.3. IL-17
IL-17 is a pro-inflammatory cytokine which derives its origin from rodent T cells (Gaffen
2008). It is produced by a family of specialized T helper cells (Th17) as an outcome of
IL-23 stimulation. Until recently, the role of IL-17 has also been highlighted in innate as
well as adaptive immunity. Several studies have reported a disputable role of IL-17 in
protection and promotion of inflammatory diseases (Miossec, Korn et al. 2009). IL-17 is
known for its ability to ward off bacterial invasion at various sites of infection thus
safeguarding the defensive immune response (Jin and Dong 2013). We were interested in
studying IL-17 to increase our knowledge on the possible role of IL-17 in the
pathogenesis of periodontal diseases. This cytokine can promote inflammation, assist
immune responses and stimulate bone resorption by osteoclastogenesis in association
with receptor activator of NF-kappaB (RANK) and RANK ligand (RANKL) (Takahashi,
Azuma et al. 2005) (Chabaud and Miossec 2001). IL-17 can accentuate the inflammatory
response by working in synergy with other inflammatory cytokines like TNF-α and IL-1β
(Chabaud, Fossiez et al. 1998) (Onishi and Gaffen 2010).
1.3.4. TNF
Tumor Necrosis Factor or TNF includes two protein subsets – TNF-α, and TNF-β. Of
these two TNF-α has been identified as a ‘major inflammatory cytokine’ for not only
being a key player in periodontal tissue destruction but also exhibiting toxic response to
the host tissue (Gokul, Faizuddin et al. 2012). It has been located in major abundance in
the gingival crevicular fluid and serum (Garlet 2010, Di Benedetto, Gigante et al. 2013).
The levels of TNF-α in the gingival crevicular fluid can be used as a good biochemical
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‘marker’ of periodontal disease (Gokul, Faizuddin et al. 2012). TNF-α promotes
osteoclastogenesis in several inflammatory conditions like periodontitis, rheumatoid
arthritis, orthopedic implant failures and peri-implantitis (Zhang, Heulsmann et al. 2001,
Garlet 2010). It is also known to increase the response of fellow cytokines like IL-1β and
IL-6 during inflammatory conditions (Garlet 2010, Di Benedetto, Gigante et al. 2013).
Expression of inflammatory mediators, chemokines, matrix metalloproteinase are some
of the mechanistic of TNF-α in periodontal disease in a synergistic relationship with IL-1
(Graves and Cochran 2003).
Anti-inflammatory cytokines are soluble or cell-surface molecules that reduce
inflammation by directly antagonizing the function of pro-inflammatory cytokines. A few
are summarized below:
1.3.5. IL-10
Interleukin 10 (IL-10) plays a protective role in inflammatory diseases by suppressing the
host immune response to bacterial invasion thereby limiting damage to the host (Iyer and
Cheng 2012). Major sources of IL-10 include T helper cells, monocytes, macrophages
and dendritic cells (Ouyang, Rutz et al. 2011) (O'Garra, Barrat et al. 2008). IL-10 is
popular amongst researchers for its extensive role in combating increased inflammation
and bone resorption specific to periodontal disease. A study indicated that IL-10 was
more predominant in the gingival crevicular fluid of gingivitis patients compared to those
who had progressed to periodontitis which suggests the anti-inflammatory nature of IL10 (Feno Al 2014).
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Additionally, IL-10 can contribute to bone homeostasis by maintaining the balance
between osteoblastic and osteoclastic activity (Zhang, Chen et al. 2014).
1.3.6. TGF-β
Transforming growth factor β (TGF-β), is a multifunctional cytokine that regulates
multiple biological processes, including embryonic development, adult stem cell
differentiation, immune regulation, wound healing, and inflammation (Lifshitz and
Frenkel 2013). After having been quantified in the serum and gingival crevicular fluid of
humans with periodontitis, TGF-β has been established as an important marker of
periodontal disease progression. Higher levels of TGF-β were expressed in moderate
periodontitis with a gradual decline in levels as the disease became severe. Thus, TGF-β
has established itself as an important anti-inflammatory cytokine implicated in the
pathogenesis of periodontal disease (Skaleric, Kramar et al. 1997).
1.4.

PERIODONTAL DISEASE AND BONE LOSS

One of the main factors that separate gingivitis from periodontitis is attachment loss,
which is an important hallmark of periodontal disease. There is loosening of the tooth
from the alveolar bone socket due to destruction of the junctional epithelium (epithelium
that connects the tooth to the bone). This bone loss or scientifically ‘bone resorption’ is
caused by none other than bone resorbing cells or osteoclasts.
Osteoclastogenesis is the formation of bone resorbing cells or osteoclasts. Osteoclasts are
large multinucleated cells, which are differentiated from the hematopoietic stem cell
lineage. They are characterized by presence of multiple nuclei in the cytoplasm and a
ruffled border on the cell surface, which is separated from the surrounding tissue by a
11

clear zone. This ruffled anatomy is an extensive cell surface area believed to be essential
for osteoclastic activity. The clear zone also aids in resorption (Florencio-Silva, Sasso et
al. 2015). Secretion of enzymes and other functions related to transport or digestion of
products in and out of the cell are done via vacuoles or vesicles (Holtrop and King 1977).
Lysozymes are rich in Tartrate-resistant acid phosphatase which is an important
biochemical marker of osteoclast function and bone resorption (Halleen, Tiitinen et al.
2006).
On the contrary, osteoblasts are cuboidal cells responsible for bone formation (FlorencioSilva, Sasso et al. 2015). To maintain bone health, osteoblasts and osteoclasts should
function in concert. In other words, the amount of bone deposition should be same as the
amount of bone resorption (Tanaka, Nakayamada et al. 2005). Any abnormality or
imbalance in this activity leads to bone diseases like osteoporosis (Feng and McDonald
2011).

Figure 1. 20x microscopic image of Tartrate resistant acid phosphatase positive
(TRAP) osteoclasts characterized by large round appearance and presence of
multiple nuclei in the cytoplasm surrounded by RAW 264.7 monocytes.
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1.5.

NF-κB SIGNALING PATHWAY AND PERIODONTAL DISEASE

Nuclear factor kappa B (NF-κB) is a family of structurally-related proteins or
transcription factors which are expressed in response to an inflammatory stimulus (Park,
Krishnan et al. 2005). They were first discovered by Sen and Baltimore in 1986 in
lymphocytes but later found associated with several mammalian cells (Zhang and Ghosh
2001). These factors are important in regulation of immune and inflammatory responses,
cell apoptosis, proliferation, differentiation and survival (Oeckinghaus and Ghosh 2009).
Over-activation of

NF-κB causes the pathogenesis of various diseases like

cardiovascular disease, rheumatoid arthritis, cancers, and periodontitis (Nichols, Fischer
et al. 2001, Ross, Stagliano et al. 2001, Valen, Yan et al. 2001, Okamoto 2006) (Gilmore,
Gapuzan et al. 2002).
The NF-κB protein family has two distinct subsets: the “NF-κB” proteins, P105 and
p100, and “Rel” proteins, c-Rel, RelB, and RelA (aka p65). The C-terminal transcription
domains on Rel proteins is involved in the transcription process. The NF-κB subfamily
proteins form dimers with Rel proteins in order to initiate transcription (Gilmore, 2006).
Rel/NF-κB is activated in response to a wide variety of stimuli like TNF-α, IL-1, T-cell
activation signals, growth factors, and stress inducers (Barnes and Karin 1997).
Pathways involved in NF-κB activation are broadly classified into 2 main ones Canonical or classical and non-canonical pathway (alternative pathway). The canonical
pathway is involved in innate immunity and non-canonical in adaptive immunity
(Bonizzi & Karin 2004). In canonical NF-κB activation, it is compromised of p65 and
p50 subunits (Barnes and Karin 1997). Under normal conditions, NF-κB is sequestered in
the cytoplasm as an inactive complex with the inhibitory protein IκB (Ghosh et al 1998,
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Gilmore 2006). IKK α, IKK β and the regulatory protein NF-κB essential modifier (IKK
γ or NEMO) together constitute the IKK complex (Hacker and Karin 2006). Upon
stimulation, IκB is phosphorylated by activated IKK complex, resulting in ubiquitination
and degradation of IκB (Chen and Ghosh 1999). Consequently, NF-κB becomes free to
translocate to the nucleus where it initiates the expression of NF-κB-dependent genes
(Hayden and Ghosh 2004, Oeckinghaus, Hayden et al. 2011). The broad spectrum of
genes that are expressed modulate many physiological processes, in this circumstance,
inflammation and host response (Pahl 1999).
On the other hand, non-canonical pathway activates p100/RelB complexes through
IKKa-mediated phosphorylation (Beinke, Belich et al. 2002, Karin and Lin 2002,
Tergaonkar 2006).
The NF-κB pathway is an important mediator for pro-inflammatory cytokines,
chemokines and adhesion molecules (Lawrence 2009). Osteoclast formation also requires
the downstream signaling of RANKL/RANK pathway, which is mediated through NF-κB
(Yamaguchi, Weitzmann et al. 2012).
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Figure 2. Schematic depiction of the NF-κB pathway.
Binding of pathogen virulence factor to TLR activates NF-κB signaling, which leads to
production of pro-inflammatory cytokines. Binding of RANKL to ligand RANK activates
downstream signaling of the NF-κB pathway and osteoclastogenesis.
1.6.

PERIODONTAL PATHOGENS, P. gingivalis AND NF-κB SIGNALING

PATHWAY
NF-κB (Nuclear factor kappa-light-chain-enhancer of activated B cells) pathway is
known to be stimulated by bacteria and its byproducts which also regulate around 150
target genes (Pahl 1999). The periodontal bacteria that play pivotal roles in induction of
NF-κB

signaling

are

Aggregatibacter

actinomycetemcomitans,

Fusobacterium

nucleatum, Tannerella forsythia (formerly Bacteroides forsythus), Porphyromonas
gingivalis, Prevotella intermedia, Treponema denticola. (Kobayashi-Sakamoto, Hirose et
al. 2004, Walter, Zahlten et al. 2004) (Hasebe, Yoshimura et al. 2004, Huang, Zhang et

15

al. 2004, Kim, Ha et al. 2004, Tiranathanagul, Yongchaitrakul et al. 2004, Tanabe, Bodet
et al. 2008). Studies have shown that bacterial lipopolysaccharide (LPS) is responsible for
activation of NF-κB pathway (Sen and Baltimore 1986).
1.7.

NF-κB SIGNALING PATHWAY AND P. gingivalis

Lipopolysaccharide is the major component of the outer cell membrane (cell wall) of P.
gingivalis and is a major factor responsible for its virulence potential (Mysak, Podzimek
et al. 2014). This biomolecule is particularly of interest to researchers because of its
ability to induce the NF-κB signaling pathway and inflammation (Ding, Darveau et al.
2017). LPS is a complex of three segments with highly variable and conserved
phosphorylated glucosamine disaccharide regions. They are lipid A which forms the
matrix of the outermost membrane, highly variable O polysaccharide and a conserved
core oligosaccharide that links Lipid A to the O -polysaccharide (Raetz and Whitfield
2002). Pathogen-associated molecular pattern (PAMP) are a group of elements specific to
the bacteria which get recognized by pattern recognition receptors (PRRs) present on
innate immunity cells (Mogensen 2009). Lipid A part of this complex is the bioactive
center that is recognized by a pattern recognition receptor, Toll-like receptor 4. LPS
upregulates the expression of nuclear factor-κB (NF-κB) (Wang, Oido-Mori et al. 2001).
P.

gingivalis

LPS

induces

production

of

pro-inflammatory

cytokines

and

osteoclastogenesis through NF-κB (Choi, Moon et al. 2005). This in turn induces
periodontal tissue destruction (Mysak, Podzimek et al. 2014). A group of researchers
established that P. gingivalis disrupted the homeostasis of osteoblasts and osteoclasts by
hampering the demineralization process thus leading to alveolar bone loss (Zhang,
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Swearingen et al. 2010). These virulence factors make it very easy for P. gingivalis to
dwell in periodontal tissues thereby exaggerating the host immune response.
1.8.

NF-κB, OSTEOCLASTOGENESIS, RANKL/RANK/OPG Pathway

As mentioned earlier, osteoclastogenesis is the process of formation of bone resorbing
cells or osteoclasts. The importance of RANKL/RANK pathway has been well
documented in regard to osteoclastogenesis. It has been established that NF-κB pathway
is downstream of RANKL/RANK pathway which is pivotal in osteoclastogenesis (Boyce
2013).
Receptor activator of nuclear factor (RANK) and its ligand (RANKL) work hand in hand
and are well known for their role in bone turnover and immune system (Nagy and
Penninger 2015). Discovered in the 1990’s, receptor activator of nuclear factor-κB ligand
(RANKL)/RANK/osteoprotegerin (OPG) system is considered a breakthrough in bone
biology for exhibiting roles beyond mere osteoclast regulation and survival (Liu and
Zhang 2015). Interestingly, it has been located in several other sites such as mammary
glands, lymph nodes and brain tissue (Liu and Zhang 2015).
RANK is a type 1 homotrimer transmembrane protein and affiliate of the Tumor Necrosis
Receptor Family (TNFR). Osteoclasts and their precursors express RANK, which binding
to RANKL to regulate osteoclastogenesis and osteoclast function (Boyce and Xing 2007).
Osteoprotegerin (OPG), secreted by osteoblasts and acts as a negative regulation
mechanism by blocking the interaction of RANK with RANKL, and thus preventing
bone resorption (Boyce and Xing 2007). RANKL/RANK/OPG Pathway is activated via
stimulation of NF-κB and hence is considered the main orchestrator of osteoclastogenesis
(Narita, Kobayashi et al. 2009, Florencio-Silva, Sasso et al. 2015).
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1.9.

FRUITS IN HEALTH

As the famous proverb goes, ‘We are what we eat,’ food consumption contributes to
human health, including the oral health. Fruits and vegetables comprise a massive
constituent of food which is universally advocated as healthy. According to dietary
guidelines for Americans (2010), one-half of your plate should amount to fruits and
vegetables. Fruits are widely accepted as “health foods” because they are rich in dietary
fibers, minerals, vitamins, and antioxidants. They are fundamentals in human nutrition as
sources of nutrients and non-nutritive food constituents in addition to decreasing risk
levels of disease. For decades, fruits have been proved as beneficial for teeth and
periodontal tissues. The favorable outcome of fruit on the oral tissues has been attributed
to the chewing, exhilarating the salivary flow, and release of several acids which play a
major role in maintaining systemic health (Blignaught and Grobler 1992).
1.10.

GRAPES AND ORAL HEALTH

Researchers are on the quest for finding natural products capable of decreasing oral
inflammation by inhibition of the NF-κB pathway. Some of these include fruits like
grapes. A diet of grapes, (and fruits in general), is associated with health and reduced
inflammation (Nanri, Yamada et al. 2017) (Myint, Welch et al. 2007). Humans have been
using grapevine (Vitis spp.) products as early as 3500-2900 B.C. (Bowers et al. 1999).
Vitis vinifera also recognized by the common name grape, is the most cultivated food
crop worldwide due to its extensive application in wine, dried fruit and juice production
(Lodhi and Reisch 1995) (Torregrosa, Bigard et al. 2017). Data reported by the United
States; Economic Research Service; US Department of Agriculture states that the U.S.
per capita consumption of fresh grapes amounted to 8.1 pounds in 2016. It is one unique
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fruit that is implicated worldwide in health research literature for the presence of several
phytonutrients, especially in its skin and seed. Grapes and grape seeds are rich in
polyphenolic compounds like monomeric catechin and oligomeric pro-anthocyanidins
(Monagas, Gomez-Cordoves et al. 2003). They belong to the family of natural
compounds called flavonoids, which are rich in fruits and vegetables and are responsible
for imparting the flavor and color (Ross and Kasum 2002). The structure is composed of
flavanol units linked by inter-flavan bonds. Flavonoids have gained popularity among
researchers due to increased awareness regarding the use of natural products available to
combat inflammatory diseases like periodontitis (Ross and Kasum 2002).
Grape comprises a combination of ingredients: (+)-catechin and (–)-epicatechin; (–)
epicatechin 3-O-gallate, dimers, trimers, tetramers, and their gallates; and pentamers,
hexamers, heptamers, and their gallates (Gabetta, Fuzzati et al. 2000). They possess
extensive biological properties, including anti-oxidative, anti-aging, cytoprotective,
cardio-protective, anti-tumor, antibacterial, antiviral, and anti-inflammatory (Bagchi, Sen
et al. 2003) (Kempuraj, Madhappan et al. 2005) (Middleton, Kandaswami et al. 2000).
The antibacterial properties seem to have an effect on oral bacteria and further suppress
periodontal inflammation (Bonifait and Grenier 2010). Although the mechanism is still
unclear, they are believed to target NF-κB pathway (Yang, Xian et al. 2018), which is an
attractive target in many inflammatory diseases like rheumatoid arthritis and cancer (Ross
and Kasum 2002). Periodontitis, being a chronic disease of similar inflammatory nature
may thus benefit from grape components. Additionally, studies have reported that grape
components exhibit little toxicity in vivo and in vitro (Chu Hongqian et al., 2015).
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Nuclear factor-kappaB (NF-κB) is a crucial transcriptional controller of the inflammatory
processes. Numerous investigations have proved that the cytokine genes, namely TNF-α,
IL-6, and IL-1β are expressed through the activation of NF-κB (Shalit, Halperin et al.
2006, Senthil Kumar and Wang 2009). The murine macrophages cell line RAW 264.7
was discovered 30 years ago from BALB/c mice and is considered as an appropriate
model for the in-vitro study of macrophages (Raschke et al., 1978). Bacteria stimulate
cells to produce reactive oxygen species (ROS). These are critical for bacterial resistance
but generate high levels of oxidative stress leading to periodontal tissue and bone
destruction. A study showed that grape seed extract (GSE) strongly decreased the
production of ROS by LPS-stimulated macrophages (Houde, Grenier et al. 2006).
Osteoclasts are multinucleated cells that play a pivotal role in bone resorption.
Involvement of receptor activator of nuclear factor kappaB ligand (RANKL) is
responsible for the abnormal activation of osteoclasts (Takayanagi, Iizuka et al. 2000).
GSE may intensely inhibit osteoclastogenesis by suppressing osteoclast differentiation
and promoting osteoblast differentiation and thus may be beneficial in anti-inflammatory
treatment accompanying bone destruction (Park, Park et al. 2012). A question worth
addressing is the potential of grape components to positively modulate periodontal health.
1.11.

MICE PERIODONTAL DISEASE MODEL

Animal models are preferred to study the microbiological, biochemical and
immunological aspects of periodontal disease. The mouse is a common model in
experimental periodontitis as a critical tool to analyze its pathogenesis and explore
potential therapeutic approaches. It bears similarity to man in terms of periodontal
anatomy, structure and organization of the tissue, oral sulcular epithelium, junctional
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epithelium, periodontal collagen fibers and alveolar bone. Additionally, development and
composition of dental plaque and histopathology of periodontal lesions also bears a
striking resemblance to man which makes the murine model a reasonable fit for
experimental periodontitis (Klausen 1991).
In summary, periodontitis is one of the most prevalent chronic inflammatory disease.
Periodontal pathogens induce production of pro-inflammatory cytokines and
osteoclastogenesis through NF-κB signaling which in turn causes periodontal tissue
destruction (Choi, Moon et. al 2005). It would be beneficial to find a natural means to
down-regulate oral inflammation and bone loss in periodontitis. Grape powder extract
contains numerous chemicals of different characteristics and function. Previous literature
showed that certain grape components like catechin and pro-anthocyanidins elicit antibacterial and anti-inflammatory properties, while the effect of grape consumption on
periodontitis is still unknown. We would like to explore the effects of grape components
using in vitro and in vivo methods. The goal of our research was to determine if grape
components have an effect on bacterial growth, inflammation and osteoclastogenesis in
vitro and inflammation and bone loss in vivo.
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HYPOTHESIS

We hypothesize that grape powder extract inhibits P. gingivalis growth, suppresses proinflammatory cytokine production and inhibits osteoclastogenesis in vitro. We also
hypothesize that grape powder inhibits gingival inflammation and prevents bone loss in a
murine model.
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CHAPTER 2. MATERIALS AND METHODS
2.1.

In-vitro EXPERIMENTS

In order to better understand the benefits of consuming grapes in preventing periodontal
diseases, we tested the function of grapes in a series of in vitro experiments. We used
grape powder extract, which is produced from whole California grapes and provided by
the California Table Grape Commission. California grape extract (1.25 g) was obtained
from 250 g of grape powder (blend of 2011 and 2013 vintages) by adsorption of the
hydrophobic compounds, including flavonoids, onto Diaion HP-20 porous sorbent (anion
resin), washing with water to remove grape sugars (glucose, fructose) and nondissolvable grape components, and then eluting with methanol. This grape powder extract
was further dissolved in an organic solvent Dimethyl Sulfoxide (DMSO) (SigmaAldrich,
St Louis.) as stocking solution before further being diluted in medium as working
solution. We used murine RAW 264.7 cells (ATCC CLR-2278) (mouse monocytes) and
human monocytic THP1-Blue cells™ (Invivogen), stably transfected with NF-κB
inducible reporter system as model cells to investigate whether grapes can efficiently
modulate osteoclastogenesis and pro-inflammatory cytokine production and block NFκB signaling. The cells were maintained as frozen stocks. RAW 264.7 and THP1-Blue
cells™ were cultured in DMEM (Dulbecco’s Modified Eagles Medium) with high
glucose. Monocytes can differentiate into macrophages, which play a key role in immune
reactions, allergy, and inflammation (St-Denis, Chano et al. 1998). Raw cells can also be
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further differentiated into osteoclasts, and also are capable of producing proinflammatory cytokines important for periodontitis progression (Bertolini, Ottani et al.
2002). RAW 264.7 cells are sensitive, easy to propagate and efficient for DNA
transfection (Sigma Aldrich). All these factors provided us the rationale for using the
RAW 264.7 cell line since we were interested in studying pro-inflammatory cytokine
expression and osteoclastogenesis in our experiments.
P. gingivalis ATCC® 33277™ was purchased from American Type Culture Collection
(Manassas, VA) and maintained as frozen stocks. The medium for P. gingivalis was Gifu
Anaerobic medium (GAM broth, Tokyo, Japan) and grown under anaerobic conditions
(80% N2, 10% H2, and 10% CO2) at 37oC. The culture plates for P. gingivalis were
prepared using GAM broth (Nissui Pharmaceutical, Tokyo, Japan), BD Difco Agar™
(Thermo Fischer Scientific) and 5% sheep blood (Thermo Fischer Scientific). LPS used
was of the form LPS-PG (Ultrapure) obtained from Invivogen. The concentrations of
LPS used were 1 µg/ml and 10 µg/ml.
2.1.1. ORAL BACTERIA
Test the inhibition of bacterial growth by grape extract
An overnight culture of 5 × 105 CFU/ml of P. gingivalis 3327 (ATCC®) grown in Gifu
anaerobic medium (GAM broth, Tokyo, Japan) at MOI of 10:1 was inoculated into 1.5
ml micro centrifuge tubes (Eppendorf). The next morning, the P. gingivalis was treated
with different dosages (0, 0.0625, 0.125, 0.5 mg/ml) of grape powder extract (California
Table Grape Commission). Following serial dilution, 50 µl of the culture was plated on
blood agar plates. These tubes were incubated at 37 °C for 24 h. The bacterial growth was
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determined by plating on blood agar in anaerobic conditions for Colony Forming Units
(CFU). 7-10 days later, the number of bacterial colonies was counted.
2.1.2. PRO-INFLAMMATORY CYTOKINE EXPRESSION
Test the ability of grape powder to prevent P. gingivalis induced pro-inflammatory
cytokine IL-6 production
105 Murine RAW 264.7 cells (ATCC CLR-2278) were stimulated with P. gingivalis LPS
overnight in 96 well culture plate. Concentration of LPS used was 1 µg/ml. This
concentration was in accordance with previous literature and after testing several
concentrations to achieve a reasonable IL-6 signal. Initially the cells were treated with
different dosages (0, 25, 50, 100 µg/ml) of grape powder extract and incubated at 37 °C
for an hour. One hour later the cells were stimulated with LPS. LPS used was in an
ultrapure form obtained from P. gingivalis (Invivogen). Cell culture supernatant was
harvested after incubating overnight. The supernatant was tested for the expression of the
critical cytokine, IL-6, using enzyme linked immunosorbent assay (BD biosciences, San
Diego, CA).
2.1.3. P. gingivalis LPS INDUCED NF-κB ACTIVATION
To test the ability of THP1-Blue cells™ to block P. gingivalis LPS-induced NF-κB
activation
105 THP1-Blue cells ™ (Invivogen) were treated with different dosages (0, 25, 50, 200
µg/ml) of grape powder extract in a 96 well culture plate and incubated at 37 °C for an
hour. One hour later the cells were stimulated with LPS. LPS used was in an ultrapure
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form obtained from P. gingivalis (Invivogen). Concentration of LPS used was 10 µg/ml.
This concentration was chosen after testing several concentrations to achieve an
appropriate level of NF-κB activation. Cell culture supernatant was harvested after
incubating overnight. Activity of NF-κB-inducible alkaline phosphatase was determined
by colorimetric activation at a 1-hour time point using Quanti Blue reagent.
2.1.4. OSTEOCLASTOGENESIS
Test the inhibition of osteoclastogenesis by grape extract
103 murine monocyte cell line (RAW 264.7 cells) was cultured in 96-well plates in 150 μl
of α-MEM medium supplemented with 10% fetal bovine serum (FBS), 1% penicillinstreptomycin, and 100 ng/ml murine soluble RANKL (sRANKL) (Peprotech). 200 µg/ml
of grape powder extract was added into the cell culture. Seven days later, the cultures
were fixed in 10% formalin and stained for the enzyme tartrate-resistant acid phosphatase
(TRAP), an osteoclast marker, using the Leukocyte Acid Phosphatase TRAP kit (SigmaAldrich®) for 15 minutes. The number of multinucleated TRAP-positive cells in each
well were counted microscopically which represented the multinucleated osteoclasts
(Jacome-Galarza, Lee et al. 2013).
2.2.

In-vivo EXPERIMENTS

2.2.1. MICE
Mice of 8-10 weeks old were purchased from Jackson lab and used in the experiments.
Mice strain used was C57BL/6 mice model for the ligature model and BALB/c mice for
the Baker model. C57BL/6 mice have been reported to show resistance to bone loss in the
Baker model (Baker, Dixon et al. 2000). All these factors favor the use of. BALB/c strain
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in the baker model. Animals were kept in animal facilities at the University of Louisville.
All handling and processing were approved by Institutional Animal Care Committee, and
in appliance with the established Federal and State policies.
2.2.2. MURINE LIGATURE INDUCED PERIODONTITIS MODEL
Ligature induced periodontitis model is a straightforward procedure used to induce
alveolar bone loss in mice. A silk ligature is tied around typically the maxillary second
molar, placed in the gingival sulcus. This specific site has been highlighted as appropriate
for maximum data validity and reproducibility (Abe and Hajishengallis 2013). Ligatureinduced periodontitis model is selected because of its ability to induce periodontitis in a
shorter period of time by promoting inflammation and bone loss. The ligature acts as a
niche for bacterial plaque and facilitates bacterial accumulation and inflammation.(Abe
and Hajishengallis 2013) (Graves, Fine et al. 2008, Oz and Puleo 2011). It is also
advantageous in terms of predictability of events and duration resulting in alveolar bone
loss (Graves, Fine et al. 2008) (Li and Amar 2007) (Bezerra, de Lima et al. 2000). We
were particularly interested in studying inflammatory response in the ligature model due
to its ability to induce strong and intense inflammation in a shorter time period (Abe and
Hajishengallis 2013).
Mice were weighed prior to the experiments. Grape powder diet consumed by the select
mice group was specially formulated by California Table Grape Commission by adding
5% grape powder to the regular mouse diet. Diet was prepared in accordance with
calculating mouse body weight and average human consumption of grape by humans.
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Figure 3. Schematic depiction of the protocol for periodontitis induction in vivo
using ligature model on C57BL/6 mice.
The mice were ligated with 6-0 black silk suture on day 1 and infected with 109 colonyforming units (CFU) of P. gingivalis (33277) in 2% carboxymethylcellulose (CMC) (day
1, 3 and 5) followed by sacrifice of mice on day 8. The mice were fed with grape powder
diet (mouse food fortified with 5% grape powder) or control diet. Gingival tissues were
harvested to check expression of pro and anti- inflammatory cytokines by qPCR.
Numbers indicate the days.
There were 4 groups of mice: 1. Sham + Control (no ligation, no P. gingivalis infection,
control diet), 2. Ligated + Control (ligation + P. gingivalis infection + control diet), 3.
Sham + Grape (no ligation, no P. gingivalis infection, on grape powder diet), 4. Ligated +
Grape (ligation + P. gingivalis infection + grape powder diet) Each group had 5 mice
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which was calculated according to a power analysis that required sample size was 5 mice
for a statistical power of 80%.
On the first day, mice groups 2 and 4 were ligated using a 6-0 black silk suture around
the maxillary second molar placed in the gingival sulcus. Additionally, the same mice
groups were orally infected (oral gavage) with 1 x 109 colony-forming units (CFU) of P.
gingivalis (3327; American Type Culture) in 2% carboxymethylcellulose (CMC) to
facilitate adhesion of the bacteria and then infected for a total of 3 times every other day.
Infection was done using a gavage needle around the maxillary molars on both sides.
Mice groups 3 and 4 consumed a mouse food diet fortified with grape powder (5%)
obtained from California Table Grape Commission. Mice in groups 1 and 2 were fed with
regular or control diet. The mice were kept for seven days. On the eighth day, the mice
were sacrificed, and gingival tissues were harvested. Gingival expression of periodontal
markers was determined by Quantitative Real-time PCR. Numbers indicate the days.
2.2.3. BAKER MODEL
Another model was developed by Baker and his team in which mice are orally infected
with P. gingivalis leading to alveolar bone loss (Baker, Evans et al. 1994). This model
allows for controlled environmental conditions and infection levels (Hart, Shaffer et al.
2004). It is aimed at allowing mice to naturally develop periodontitis over a period of
time similar to development of periodontitis in humans. It closely mimics the chronic
nature of periodontitis. Alveolar bone loss is detected after 10 weeks. Apart from being a
fairly inexpensive and experimentally induced disease model, mice possess a similar
molar structure to humans (Oz and Puleo 2011). All these factors make the baker model a
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favorable model to detect bone loss levels in mice after being orally infected with P.
gingivalis.
Grape powder diet consumed by the select mice groups was specially formulated by
California Table Grape Commission by adding 5% grape powder extract to the regular
mouse diet. Diet was prepared in accordance with calculating mouse body weight and
average human consumption of grape by humans.

Figure 4. Schematic depiction of the protocol for periodontitis induction in vivo
using baker model on BALB/c white mice.
Grape powder diet (mouse food fortified with 5% grape powder) and 109 colony-forming
units (CFU) of P. gingivalis (3327) oral infection in 2% carboxymethylcellulose (CMC)
around maxillary molar teeth 5 times a day for 8 days followed by sacrifice of mice after
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2 months and subsequent harvest of maxillary skulls to check bone loss microscopically.
Numbers indicate the days.

There were 4 groups of mice - 1. Sham + Control (no P. gingivalis infection + control
diet), 2. P. gingivalis + Control (P. gingivalis infection + control diet), 3. Sham + Grape
(grape powder diet), 4. P. gingivalis + Grape (P. gingivalis infection + grape powder
diet). Each group had 5 mice which was calculated according to a power analysis that
required sample size was 5 mice for a statistical power of 80% bone loss.
Mice groups 2 and 4 were orally infected (oral gavage) with 1 x 109 colony-forming
units

(CFU)

of

P.

gingivalis

(3327;

American

Type

Culture)

in

2%

carboxymethylcellulose (CMC) to facilitate adhesion of the bacteria and then infected for
a total of 5 times every other day for 8 days. Infection was done using a gavage needle
around the maxillary molars on both sides. Mice groups 3 and 4 consumed a mouse food
diet fortified with grape powder (5%) obtained from California Table Grape Commission.
Mice groups 1 and 2 consumed a regular or control diet. The mice were kept for 2 months
allowing the P. gingivalis to grow and colonize the oral cavity. After 2 months, the mice
were sacrificed with 3% isoflurane (40mg/kg) followed by cervical dislocation. Maxillary
jaw bones were harvested. Numbers indicate the days.
2.2.4. GINGIVAL TISSUE HARVEST IN LIGATURE MODEL
Gingival tissues of the mice were excised from around the maxillary molars for mRNA
harvest. These tissues were immersed in buffer RLT (Qiagen). The gingiva samples were
frozen at -80 degree till ready for RNA isolation. RNA was isolated using RNeasy Mini
kit (Qiagen). RNA was reverse-transcribed using the High-capacity cDNA Archive Kit
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(Applied Biosystems, Foster city, CA, USA) and qPCR was performed using the ABI
700 System, following the manufacturers protocol (Applied Biosystems).

mRNA

expression of pro-inflammatory markers - IL-6, TNF-α, IL-17, IL-1β and antiinflammatory markers – TGF-β and IL-10 were determined by quantitative Real-time
PCR.

Figure 5. Schematic depiction of mice maxilla showing molar and incisor teeth and
surrounding gingiva.
Numbers indicate the incision sites made. Incision ①, ②, ③ were made first. The red
triangle part of the gingiva was grasped, and the lingual part of gingiva was pulled. Then,
incision ④ was made and the black part of the gingiva grasped, and the buccal part of
the gingiva pulled.
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2.2.5. HARVEST OF MAXILLARY JAW BONE AND ALVEOLAR BONE LOSS
EVALUATION IN BAKER MODEL
The harvested skulls from Baker model mice were immersed in water and subjected to
boiling at 15psi for 10 minutes. During the process of de-fleshing, the maxillae were
detached from the skulls. Maxillae were cleaned gently with micro brushes and water and
immersed overnight in 3 % hydrogen peroxide. The following morning, the skulls were
washed in water, cleaned again and left to air-dry. Once completely dry, the skulls were
stained with 0.5 % eosin for 5 minutes followed by 1 % methylene blue for 1 minute
(Both bought from Ricca Chemical Company, TX, USA).
Distance from cementoenamel junction to alveolar bone crest (CEJ/ABC) on second
molar (three sites corresponding to mesial-buccal cusp, buccal groove, and disto-buccal
cusp) and the sites corresponding to mesio-buccal cusp, disto-buccal cusp and distal
groove of the first molar, and buccal cusp of the third molar were measured. This was
done on the left and right buccal side. To calculate pro-inflammatory periodontal bone
loss, the mean CEJ-ABC distance from the group of control mice was subtracted from the
CEJ-ABC distance for each experimental group of mice. Bone loss was visualized by
methylene blue/eosin staining and quantified using a Nikon SMZ 800 dissecting
microscope (40X, Nikon Instruments Inc., Melville, NY, USA) fitted with a Boeckeler
VIA-170K video image marker measurement system (Boeckeler Instruments Inc,
Tucson, AZ, USA). The results were presented in mm; the values indicated bone loss
relative to controls.
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Figure 6. Microscopic picture of mice maxillary teeth showing the seven sites of
measurement from the CEJ to ABC (depicted by black arrows) on the right buccal
side after staining with methylene blue for visualization of the CEJ (Baker model).
Arrows indicate the site of measurement from the CEJ to ABC. Measurements for all
four groups of mice were taken at fourteen different sites, 7 sites each on the right and
left side of the maxillary arch - the mesio-buccal cusp, buccal groove, and disto-buccal
cusp of the ligated 2nd molar, mesio-buccal cusp, disto-buccal cusp and distal groove of
the first molar, and buccal cusp of the third molar. Bone loss in the baker model was
calculated by subtracting the fourteen - site total CEJ-ABC distance of group Sham
control from group P. gingivalis control and group Sham grape from group P. gingivalis
grape. The results were presented in mm; the values indicated bone loss relative to
controls.
2.3.

STATISTICAL ANALYSIS

Data were evaluated by two-tailed t test. (InStat v3.06 program, GraphPad) and
differences were considered statistically significant at the p < 0.05 level.

Human Subjects: No human subjects were used in the experiment.
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CHAPTER 3.RESULTS

3.1.

In-vitro

The aim of this research was to evaluate the ability of grape powder extract to inhibit P.
gingivalis growth, suppress pro-inflammatory cytokines and inhibit osteoclastogenesis in
vitro. We also aimed to investigate the therapeutic nature of grape powder to inhibit
gingival inflammation and prevent bone loss in a murine model.

3.1.1. GRAPE POWDER EXTRACT INHIBITS P. gingivalis GROWTH.
The role of P. gingivalis as one of the key players in the pathogenesis of periodontal
disease cannot be ignored. LPS from periodontal pathogen P. gingivalis signal through
Toll-like receptors, activate the NF-κB pathway, and induce periodontal inflammation
(Coats, Reife et al. 2003). We were thus interested in studying the effect of grape powder
extract on P. gingivalis growth. Grape powder extract was prepared using DMSO as a
solvent. In order to confirm that DMSO was not responsible for decrease in the levels of
IL-6, corresponding concentrations of DMSO were treated with P. gingivalis LPS.
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Figure 7. Graphical comparison of P. gingivalis growth after treatment with
different concentrations of grape powder extract.
P. gingivalis were treated with increasing dosages of grape powder extract and incubated
anaerobically overnight after which the culture was plated on blood agar plates. After a 710-day anaerobic incubation, the plates were counted for colony forming units (CFU).
Group of plates inoculated with P. gingivalis only and DMSO were the controls.
Asterisks indicate statistically significant differences (*, p<0.05; **, p<0.01) between the
labelled groups. Data was evaluated by two tailed t test.
Grape powder extract was prepared using DMSO as a solvent. In order to confirm that
DMSO was not responsible for inhibition of P. gingivalis growth, P. gingivalis was
treated with corresponding concentrations of DMSO as controls.
In Fig 7., P. gingivalis with 0.125 mg/ml and 0.5 mg/ml concentration of grape powder
extract exhibits a significant reduction in CFU, as compared to P. gingivalis without
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grape powder extract treatment. P. gingivalis with 0.125 mg/ml and 0.5 mg/ml
concentration of grape powder extract exhibit significantly less CFU formation as
compared to their corresponding DMSO concentrations. This clearly indicates that
DMSO in the grape powder extract is not responsible for reduction in the growth of P.
gingivalis. Although P. gingivalis treated with 0.0625 mg/ml concentration of grape
powder has a reduction in CFU as compared to P. gingivalis without treatment of grape
powder extract, the difference is not statistically significant. Also, its difference with
corresponding DMSO is not statistically significant. From this data we can conclude that
grape powder extract inhibits the growth of P. gingivalis.
3.1.2. GRAPE POWDER EXTRACT INHIBITS P. gingivalis- LPS INDUCED PROINFLAMMATORY CYTOKINE PRODUCTION
As reported previously, pro-inflammatory cytokines and chemokines play a major role in
the pathogenesis of periodontitis, we wanted to investigate whether grape powder extract
will inhibit the expression of cytokine, IL-6, which is critical in periodontitis. Grape
powder extract was prepared using DMSO as a solvent. In order to confirm that DMSO
was not responsible for decrease in the levels of IL-6, corresponding concentrations of
DMSO were treated with P. gingivalis LPS.
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Figure 8. Comparison of different concentrations of grape powder extract and
DMSO on P. gingivalis-LPS induced pro-inflammatory cytokine IL-6 production in
RAW 264.7 cells.
RAW 264.7 cells were treated with different dosages of grape powder extract. Cells were
incubated at 37 °C for 1 hour and then treated with P. gingivalis LPS at a concentration
of 1µg/ml. Cells were incubated at 37 °C overnight and supernatant was measured for IL6 using ELISA. Cells treated with DMSO were used as controls. IL-6 production by the
cells without any stimulation nor treatment was labeled out as the baseline. Asterisks
indicate statistically significant differences (*, p<0.05; **, p<0.01) between the labelled
groups. Data were evaluated by two tailed t test.
In fig 8., Grape powder extract and DMSO alone at concentrations of 0, 25, 50, 100
µg/ml showed minimal expression of IL-6 indicating that they were not capable of
causing any harm on their own. Expression of IL-6 with P. gingivalis LPS without
treatment of grape powder extract (0) is the highest. Expression of P. gingivalis LPS
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induced IL-6 with 25, 50 and 100 µg/ml of grape powder extract treatment exhibits a
significant reduction, as compared to IL-6 produced without treatment of grape powder
extract. At concentrations of 25, 50, 100 µg/ml of grape powder extract treatment, LPSinduced IL-6 production was significantly reduced compared with the ones treated with
corresponding DMSO. Treatment with 25 µg/ml and 50 µg/ml of DMSO did not induce
statistically less IL-6 production. This indicates that DMSO in the grape powder extract is
not responsible for reduction in IL-6. From this data we can conclude that grape powder
extract inhibits IL-6 production in RAW 264.7 cells.
3.1.3. GRAPE POWDER EXTRACT INHIBITS P. gingivalis LPS-INDUCED NF-κB
ACTIVATION.
Although the mechanism is still unclear, some grape components are believed to target
the nuclear factor-kappaB (NF-κB) signal transduction pathway, which is an attractive
target in many inflammatory diseases like rheumatoid arthritis and cancer.
THP1-Blue cells™ are designed in a way as to monitor the NF-κB signal transduction
pathway in physiologically relevant cell lines. THP1-Blue cells™ were derived from the
human THP-1 monocyte cell line and stably transfected with an NF-κB-inducible SEAP
(secreted embryonic alkaline phosphatase) reporter construct. This enables the
monitoring of NF-κB activation by determining the activity of SEAP.
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Figure 9. Comparison of level of P. gingivalis LPS-induced NF-κB activation at
different concentrations of grape powder extract in THP1-Blue cells™.
THP1-Blue cells™ were treated with different dosages of grape powder extract. Cells
were incubated at 37 °C for 1 hour and then treated with P. gingivalis LPS at a
concentration of 10 µg/ml. Cells were incubated overnight, and supernatant was
harvested. Cells treated with grape powder extract alone is indicated by the baseline.
Activity of NF-κB-inducible alkaline phosphatase was determined by colorimetric
activation using a detection reagent Quanti-blue at a 1-hour time point. Asterisks indicate
statistically significant differences (*, p<0.05) between the labelled groups. Data were
evaluated by two tailed t test.
In fig 9., The amount of NF-κB activation by THP1-Blue cells™ treated with only grape
powder extract at different concentrations showed minimal activity of NF-κB indicating
that the grape powder extract was not capable of causing any activation on its own. With
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no grape powder extract treatment, THP1-Blue cells™ stimulated with LPS showed
highest level of NF-κB activation. After treated with grape powder extract at
concentrations of 50, 100 and 200 µg/ml, LPS-stimulated THP1-Blue cells™ showed
significant reduction in the activity of NF-κB as compared with THP1-Blue cells™
stimulated with LPS alone. From this data we can conclude that grape powder extract
inhibits P. gingivalis LPS-induced NF-κB activation in THP1-Blue cells™.
3.1.4. GRAPE POWDER EXTRACT INHIBITS RANKL-INDUCED
OSTEOCLASTOGENESIS
It has been established that alveolar bone loss is caused by the imbalance between bone
formation and bone resorption. Osteoclastogenesis is regulated through the NF-κB
pathway that is downstream of RANKL/RANK pathway. We explored the ability of
grape powder extract to directly prevent osteoclastogenesis in vitro. RAW 264.7 cells are
well-established among researchers to study the differentiation of osteoclasts (JacomeGalarza, Lee et al. 2013). Hence, the murine RAW 264.7 cell line was chosen as ideal for
this assay. In order to determine the number of TRAP positive osteoclasts, they were
counted microscopically in each well. Osteoclasts are characterized by the presence of
three or more nuclei in the cytoplasm and so cells exhibiting this distinct feature were
chosen. The number of osteoclasts in each well was counted under the microscope. Our
results proved that grape powder extract was able to effectively reduce osteoclastogenesis
(Fig. 10 and Fig. 11).
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Figure 10. Comparison of number of osteoclasts produced in RAW 264.7 cells with
RANKL at 0 and 200 µg/ml of grape powder extract and RAW 264.7 cells without
RANKL and grape powder.
RAW 264.7 cells were treated with 100 µg/ml of RANKL and 200 µg/ml of grape
powder extract. Untreated (RANKL only) and no RANKL or no grape powder extract
were used as controls. The cells were cultured for 7 days and then stained with TRAP for
15 minutes. Multinucleated TRAP positive cells were counted per well under the
microscope. Asterisks indicate statistically significant differences (*, p<0.05) between the
labelled groups. Data were evaluated by two tailed t test.
In Fig 10., RAW 264.7 cells showed no formation of Multinucleated TRAP positive cells
without the presence of RANKL. This indicates that RANKL is indeed critical for the
formation and differentiation of osteoclasts. Untreated (RANKL only) RAW 264.7 cells
showed the highest number of Multinucleated TRAP positive cells which was expected
since RANKL plays a pivotal role in regulating the RANKL/RANK pathway towards
osteoclastogenesis. RANKL only RAW 264.7 cells, when compared to untreated and
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without RANKL RAW 264.7 cells show a significant increase in number of
Multinucleated TRAP positive cells. Although RAW 264.7 cells treated with RANKL
and 200 µg/ml of grape powder extract show a significant increase in number of
multinucleated TRAP positive cells when compared to untreated and without RANKL
RAW 264.7 cells, they also showed a significant reduction when compared to untreated
(RANKL only) RAW 264.7 cells. Our results proved that grape powder extract was able
to effectively reduce osteoclastogenesis.

Figure 11. 20x microscopic images showing comparison of number of TRAP positive
osteoclasts produced in a 96 well plate in 3 different conditions
A) Untreated RAW 264.7 cells, B) RAW 264.7 cells treated with RANKL only and C)
RAW 264.7 cells treated with RANKL and 200 µg/ml of grape powder extract. The
number of TRAP positive osteoclasts per well was counted under the electron
microscope. Image C depicts a smaller number of osteoclasts in the well (RANKL +
grape powder extract) as compared to image B (RANKL only) which reflects higher
number of osteoclasts.
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3.2.

In-vivo

The aim of the in-vivo experiments was to elucidate the role of grape powder as a means
to reduce gingival inflammation and bone loss. A murine ligature-induced and baker
model was used to closely mimic periodontitis.
3.2.1. GRAPE POWDER TREATMENT DOWNREGULATES THE EXPRESSION
OF PRO-INFLAMMATORY CYTOKINES IL-6 AND TNF-α
On the basis of the ability of the grape powder extract to inhibit inflammatory cytokine
production as demonstrated by in-vitro experiments, we wanted to investigate the ability
of grape powder to reduce inflammation in-vivo. Grape powder diet was specially
formulated by California Table Grape Commission by adding 5% grape powder extract to
the regular mouse diet. Diet was prepared in accordance with calculating mouse body
weight and average human consumption of grape by humans. We used a murine-ligatureinduced periodontitis model.
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Figure 12. Comparison of gingival mRNA expression of IL-6 and TNF-α relative to
internal control gene GAPDH in four different groups of mice.
1. Sham + Control (no ligation, no P. gingivalis infection, control diet), 2. Ligated +
Control (Ligation + P. gingivalis infection + Control diet), 3. Sham + grape – grape
powder diet, 4. Ligated + grape (ligation + P. gingivalis infection + grape powder diet).
Gingival mRNA expression of IL-6 and TNF-α was determined using Quantitative realtime PCR. Asterisks indicate statistically significant differences (*, p<0.05; **, p<0.01)
between the labelled groups. Data were evaluated by two tailed t test.
Gingival expression of IL-6 and TNF-α was determined by using Quantitative real-time
PCR in four different groups of mice; 1. Mice without periodontitis induction and fed
with control diet (Sham + Control; no ligation, no P. gingivalis infection, control diet), 2.
Mice with periodontitis induction and fed with control diet (Ligated + Control; ligation +
P. gingivalis infection + control diet), 3. Mice without periodontitis induction and fed
with grape powder diet (Sham + Grape; no ligation, no P. gingivalis infection, grape
powder diet, and 4. Mice with periodontitis induction and fed with grape powder diet
(Ligated + Grape; ligation with P. gingivalis infection, grape powder diet). Maxillary
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gingiva was harvested and gingival mRNA expression for the indicated cytokines was
measured using qPCR which was normalized against GAPDH (internal control) mRNA
levels.
Group 1 mice (Sham + Control) and group 3 (Sham + Grape) showed minimal IL-6
expression, since they did not go through periodontitis induction. This indicates that
grape powder did not cause inflammation on its own. Ligation with P. gingivalis
infection induced significantly higher IL-6 expression in Group 2 mice (Ligated +
Control) and Group 4 mice (Ligated + Grape), compared with their respective
counterparts without ligation nor P. gingivalis infection (Sham + Control and Sham +
Grape). Group 4 (Ligated + Grape) mice show significantly lower expression of IL-6 as
compared to group 2 mice (Ligated + Control), indicating that grape consumption
reduced IL-6 expression. Although there is a difference in IL-6 expression between
Group 2 (Ligated + Control) and group 3 (Sham + Grape), it is not of our interests in this
project and hence has not been compared for statistical significance.
Our results showed that grape consumption induced lower TNF-α expression, since
Group 4 (Ligated + Grape) mice show significantly lower expression of TNF-α
comparing with group 2 mice (Ligated + Control).
On the basis of this data we concluded that grape consumption significantly reduces the
expression of IL-6 and TNF-α.
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Figure 13. Comparison of gingival mRNA expression of IL-17 and IL-1b relative to
internal control gene GAPDH in four different groups of mice.
1. Sham + Control (no ligation, no P. gingivalis infection, control diet), 2. Ligated +
Control (ligation + P. gingivalis infection + control diet), 3. Sham + Grape – grape
powder diet, 4. Ligated + Grape (ligation + P. gingivalis infection + grape powder diet).
Gingival mRNA expression of IL-17 and IL-1b was determined using Quantitative realtime PCR. Data were evaluated by two tailed t test.
We further tested the IL-17 and IL-1b expression in gingival tissues. Although we
observed the similar trend to IL-6 expression, there are no significant difference between
the different groups. Our data did not show that grape powder inhibited the expression of
IL-17 and IL-1b.
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Figure 14. Comparison of gingival mRNA expression of anti-inflammatory
cytokines TGF-b and IL-10 relative to internal control gene GAPDH in four
different groups of mice
1. Sham + Control (no ligation, no P. gingivalis infection, control diet), 2. Ligated +
Control (ligation + P. gingivalis infection + control diet), 3. Sham + Grape – grape
powder diet, 4. Ligated + Grape (ligation + P. gingivalis infection + grape powder diet)
using Quantitative real-time PCR. Data were evaluated by two tailed t test.
TGF-b and IL-10 are anti-inflammatory cytokines. We were interested in studying the
expression of anti-inflammatory cytokines in the gingival tissues of mice that consumed
the grape powder diet. We found no significant differences in the expression of TGF-b
and IL-10 between the groups. Our data implied that the grape consumption did not affect
the expression of anti-inflammatory cytokines TGF-b and IL-10.
Overall, our results indicate that grape powder is able to inhibit gingival inflammation in
a murine ligature-induced periodontitis model.
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3.2.2. GRAPE POWDER INHIBITS ALVEOLAR BONE LOSS IN A MURINE
BAKER MODEL
Our in-vitro experiments have already demonstrated that grape powder extract when
treated with mouse monocytes stimulated with RANKL is able to inhibit their
differentiation into osteoclasts. We were thus interested to highlight the role of grape
powder in reducing alveolar bone loss in a murine model. A baker model was used for
this purpose. Mice consumed a diet fortified with grape powder (regular mouse food +
5% grape powder).
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Figure 15. Comparison of CEJ-ABC distance and bone loss between different
groups of mice.
1. Sham + Control (no P. gingivalis infection + control diet), 2. P. gingivalis control (P.
gingivalis infection + control diet), 3. Sham + Grape (grape powder diet), 4. P. gingivalis
+ Grape (P. gingivalis infection + grape powder diet). Asterisks indicate statistically
significant differences (*, p<0.05) between the labelled groups. Data were evaluated by
two tailed t test.
Group 2 and group 4 BALB/c white mice were orally infected with P. gingivalis 5 times
a day for 8 days around the maxillary molars and then kept for a period of 2 months to
induce periodontitis. Group 1 and group 2 consumed a no grape powder (control) diet and
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group 3 and 4 consumed a grape powder diet (regular mouse diet fortified with 5% grape
powder extract). The distance from the cemento-enamel junction (CEJ) to the alveolar
bone crest (ABC) was measured at 14 predetermined sites on the maxillae and the mean
for each mouse was calculated. Bone loss in the baker model was calculated by
subtracting the fourteen-site total CEJ-ABC distance of group Sham + Control from
group P. gingivalis + Control and group Sham + Grape from group P. gingivalis +
Grape.
In Fig. 15., Group 1 (Sham mice) i.e. mice with no P. gingivalis infection and control diet
and group 3 (Sham + Grape) i.e. mice who consumed only grape powder diet showed
minimal CEJ-ABC distance. This indicates that grape powder did not cause bone loss on
its own. Group 2 (P. gingivalis + Control) had maximum CEJ-ABC distance which was
significantly higher than group 1 (Sham + Control) and group 4 (P. gingivalis + Grape).
Group 4 (P. gingivalis + Grape) showed significantly higher CEJ-ABC distance than
group 3 (Sham + Grape). Although group 3 (Sham + Grape) shows reduced CEJ-ABC
distance as compared to group 2 (P. gingivalis + Control), these groups are not related
and hence not compared for statistical significance. Bone loss was calculated as described
above. There is significant reduction in bone loss in the group of mice that consumed
grape powder diet as compared to control group of mice that consumed a control (no
grape powder) diet. This data indicates that grape powder inhibits alveolar bone loss in a
murine baker model.
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CHAPTER 4. DISCUSSION

Periodontitis is a chronic, multifactorial inflammatory disease of infectious nature which
leads to destruction of the tissues supporting the tooth. The interaction between bacteria
lodged in the dental biofilm and immune response of the host decisively affects the
progression and clinical signs of periodontal disease (Kaur, Grover et al. 2018). P.
gingivalis, a Gram-negative, anaerobic bacterium, has been studied extensively as one
member of the microbiota involved in periodontal disease progression and subsequent
bone and tissue destruction (Holt, Kesavalu et al. 1999). P. gingivalis is well known for
its function to regulate host immunity and induce oral microbiota dysbiosis, therefore
causing inflammation and collateral tissue damage (Rafiei, Kiani et al. 2017). According
to data published by the third US National Health and Nutrition Examination Survey,
antibody titers against P. gingivalis were located in the periodontal pockets of a large
adult population (Dye, Herrera-Abreu et al. 2009). This aroused our interest in studying
P. gingivalis as part of the in vitro experiments in the context of being an inducer of
chronic periodontitis.
Studies have also reported that fruit and vegetable consumption is associated with a
reduced risk of various diseases (Nanri, Yamada et al. 2017). The focus of our study was
to examine the possible favorable or detrimental effect of grape and its components on
periodontal disease. Among a number of potential oral health promoting fruits, the grape
was selected as our fruit of interest for several reasons. The fact that humans have been
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using grape and grape wine products since centuries for not only food purposes but also
several medicinal purposes (Ali, Maltese et al. 2010) and their extensive application in
the wine and juice industry (Torregrosa, Bigard et al. 2017) sparked our interest in this
unique fruit. Grapes are rich in several components which belong to a large family of
compounds called Flavonoids which are further divided into smaller components like
catechins and pro-anthocyanidins (de la Iglesia, Milagro et al. 2010). There has been
extensive research on specific grape components which paved the way to the rationale for
our study. Pro-anthocyanidins inhibit biofilm formation and adhesion of oral bacteria,
proteolytic activities of bacteria and cytokine production by immune cells (Bonifait and
Grenier 2010). Catechin has a bactericidal effect against gram-negative rods (Hirasawa,
Takada et al. 2002) and also suppresses genes associated with biofilm formation (Xu,
Zhou et al. 2012). Considering these previous studies and their results, we decided to take
a step further and thus studied the effect of whole grapes on bacterial growth,
osteoclastogenesis and inflammation in vitro and inflammation and bone loss in vivo.
There have been extensive studies testing the effect of different forms of grape – grape
seed extract, grape seed pro-anthocyanidins, catechin, epicatechin etc. on bacteria and
inflammation. Our study was unique in a way that we used grape powder extract and
grape powder of whole grapes obtained from the California Table Grape Commission for
the in vitro and in vivo experiments respectively. We hypothesized that the grape powder
extract can inhibit P. gingivalis growth, and directly prevent osteoclastogenesis and proinﬂammatory cytokines production in vitro. We also hypothesized that this grape powder
inhibits gingival inflammation and prevents bone loss in a murine model for
periodontitis.
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Grape powder extract used in the in vitro experiments was formulated in an organic
solvent DMSO and not water after establishing that the grape powder extract was
originally prepared in an organic solvent which rendered all its active and inactive
components completely soluble. We observed a dose dependent reduction in the
formation of P. gingivalis CFU after subsequent treatment with the grape powder extract.
The bacteria were subjected to higher concentrations of grape powder extract than used in
the other experiments, the highest being 0.5 mg/ml after which we observed the highest
reduction in P. gingivalis CFU. Using this concentration, although not falling in the
physiological range was justified by the fact that higher concentrations were required to
kill or inhibit the growth of oral bacteria. Also in a previous research studying the effect
of grape seed pro-anthocyanidins on P. gingivalis LPS, the minimum inhibitory
concentration of pro-anthocyanidins was established to be 0.8 mg/ml (Ci, Chen et al.
2015). We could expand our knowledge on this topic by testing the effect of grape
powder extract on the growth of other bacteria associated with the pathogenesis of
periodontal disease like Aggregatibacter actinomycetemcomitans. Considering the
current PSD model and its emphasis on periodontal disease being caused as an outcome
of dysbiosis rather than select bacteria (Hajishengallis and Lamont 2012), we could study
the effect of grape powder extract on oral microbiota. To that effect we could detect the
disease specific bacteria by employing RNA-Seq (RNA sequencing) to find out which
bacteria are more prevalent in the oral cavity and target those with our grape powder
extract.
Periodontal disease is a consequence of chronic inflammation in which pro-inflammatory
cytokines play a central role. Grape components like pro-anthocyanidins, catechin and
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epicatechin possess strong anti-inflammatory properties (Gu, Kelm et al. 2004). Proanthocyanidins from cranberries downregulated the expression of IL-6 and IL-8 in
gingival fibroblasts stimulated with LPS from select periopathogens like P. ginigivalis, A.
actinomycetemcomitans and T. denticola (Bodet, Grenier et al. 2008). To that effect, we
studied the expression of IL-6 as an outcome of P. gingivalis LPS induced stimulation
with prior grape powder extract treatment. We chose LPS over other stimulants due its
easy availability and stable lipid nature. Concentration of 1 µg/ml LPS was decided after
considering previous literature and having been tried and tested to achieve a good
meaningful signal for IL-6 expression. From our experiment we learned that grape
powder extract could inhibit P. gingivalis LPS induced IL-6 expression in RAW 264.7
cells. Our grape powder extract was prepared in DMSO which is known to be inhibitory
as higher concentrations. As we used high concentrations of DMSO (25, 50, 100 µg/ml)
corresponding to our grape extract concentrations, we also eliminated the possibility of
DMSO interfering in the downregulation of IL-6. In future, the grape powder extract
could be tested on many more pro-inflammatory cytokines related to periodontal disease
like IL-17.
The NF-κB signaling pathway plays a crucial role in inflammation and immune responses
for being at the crossroad of various signaling pathways. Several researchers have
described the role of NF-κB as “good” when regulating immunological functions and
“evil” when it is dysregulated (Pahl 1999). Although prolonged or imbalanced activation
of NF-κB genes generates chronic inflammation, this inflammatory program may be
mediated without potentially damaging the host cells (Barkett and Gilmore 1999) which
works in favor of the “good” theory. P. gingivalis LPS induces production of pro-
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inflammatory cytokines and osteoclastogenesis through NF-κB signaling which in turn
causes periodontal tissue destruction (Choi, Moon et. al 2005). Researchers have
attempted to block this pathway at various steps with natural biomolecules.
We were thus interested in studying the level of involvement of NF-κB signaling in an
attempt to study the possible mechanism of grape powder extract. Our results indicated
that there was a dose dependent reduction in NF-κB signaling after being subjected to
grape powder extract. However, the concentration of LPS used to elicit the positive
control was ten times higher than used in our previous experiments. The reason for this
may be traced back to the weak nature of the LPS as an agonist and also indicate a
potential limitation of this assay. In contrast to our previous experiments, the
concentration of DMSO used to prepare the grape powder extract was similar in all
dosages and thus we did not require DMSO as a separate control. Our data reflected the
NF-κB signaling activity at a one-hour time point which provided us meaningful
inhibition by grape powder extract. We used THP1-Blue cells™ to study NF-κB
signaling activity due to the presence of NF-κB-inducible SEAP (secreted embryonic
alkaline phosphatase) reporter construct. The exact mechanism by which these grape
components exhibit these anti-inflammatory properties still remains an area of debate.
NF-κB plays an important pathogenic role in periodontitis (Arabaci, Cicek et al. 2010)
(Pacios, Xiao et al. 2015). Under normal conditions, in response to an infection, NF-κB is
sequestered in the cytoplasm as an inactive complex with the inhibitory protein IκB.
Upon stimulation, IκB is phosphorylated, ubiquitinated and degraded. Consequently, NFκB becomes free to translocate to the nucleus where it initiates the expression of NF-κB dependent pro-inflammatory cytokines, osteoclastogenesis and bone loss (Zhou, Su et al.
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2018). Inhibition of NF-κB translocation is possible through several mechanisms, a few
of which are a) inhibition of IKK complex, b) interfering with the translocation of NF-κB
to the nucleus. An experiment conducted by a group of researchers concluded that grape
components were able to decrease the phosphorylation of IKKa/b which suggested that
the anti-inflammatory action of grape components could at least partially be due to
inhibition of the NF-κB dependent gene transcription (Chu, Tang et al. 2016). Our
experiment also suggested the involvement of NF-κB signaling pathway. Additionally,
some other studies have also reported the involvement of MAP kinases and AkT
signaling pathways as potential targets for grape components (Lee, Kim et al. 2017).
Future studies could be directed at studying if and how the effects of grape powder
extract are mediated through these pathways.
Harmony between osteoblastic and osteoclastic activity is detrimental for maintaining an
ideal bone homeostasis (Tanaka, Nakayamada et al. 2005). Imbalance in this activity
favors osteoclastogenesis or bone resorption which is a characteristic feature of
periodontitis mediated through the NF-κB signaling pathway (Takayanagi, Iizuka et al.
2000). According to a study by Nakagawa and Yokozawa in 2002, catechin was able to
inhibit formation of osteoclasts from precursor cells (Nakagawa and Yokozawa 2002).
Similarly, we decided to investigate if our grape powder extract had an effect on the
osteoclast forming ability of RAW 264.7 cells. Based on the results obtained from our
previous experiment on NF-κB signaling, a single effective concentration of 200 µg/ml of
grape powder extract was chosen and we established that grape powder extract was
clearly interfering in the osteoclast forming ability of RAW 264.7 cells after treatment
with RANKL. We may like to experiment with different concentrations of grape powder
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extract in future and also test the effect of different grape components like catechin on
osteoclast formation and differentiation.
The anti-inflammatory properties of grape powder extract have already been highlighted
through our previous experiments. According to previous literature, grape seed extract in
the diet of laboratory mice reduced inflammatory cell number (ICN), connective tissue
attachment level (CAL), osteoclast density (OD), and higher IL-10 and TGF-b expression
in ligature induced periodontitis model (Özden, Sakallioğlu et al. 2017). We decided to
take our research a step further by investigating the effects of grape powder extract in
vivo. To achieve this, we used a murine ligature-induced model. This model allows for a
stronger and intense inflammation in a shorter time period (Abe and Hajishengallis 2013)
so it was specifically chosen to study inflammation through studying the expression of
some important pro-inflammatory cytokines – IL-6, TNF-α, IL-17 and IL-1b and antiinflammatory cytokines IL-10 and TGF-b. These cytokines were selected on the basis of
previous literature as the most potent in relation to periodontal disease. The ligated mice
were also infected with P. gingivalis to accelerate the periodontal disease process. Similar
to previous literature, select mice groups consumed a diet fortified with grape powder
(5%) which was specially formulated by the California Table Grape Commission. The
mice from control groups consumed a low fat control diet without added grape powder.
Our data reflected that grape powder extract was able to significantly downregulate the
expression of pro-inflammatory cytokines IL-6 and TNF-α (Fig 12). However, there was
no significant effect on IL-17 and IL-1b expression in spite of having a reduced trend as
compared to our positive controls (Fig 13). This might reflect 2 things – 1. IL-17 and IL1b are not as critical as IL-6 and TNF-α in the inflammatory process 2. Operator error
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while performing the assay. Although group 4 mice (ligation + P. gingivalis infection +
grape powder diet) showed higher expression of TGF-b as compared to group 2 mice
(ligation + P. gingivalis infection + control diet), the differences were not significant.
Also, the expression of IL-10 was not altered in the group 4 mice (Fig 14). Antiinflammatory cytokines are part of a feedback protective mechanism in humans and
animals that try and resolve the inflammation initiated by pro-inflammatory cytokines
which was clearly indicated by TGF-b levels in group 4 mice. We were of the opinion
that the grape powder might elicit intense protective mechanism in response to
inflammation which was also highlighted by previous research (Özden, Sakallioğlu et al.
2017). However, our data did not reflect that. This might indicate that anti-inflammatory
response is not the main target of the grape components or technical errors from our side.
At present, our data suggests that grape components are able to reduce inflammation by
targeting select pro-inflammatory cytokines. However, these cytokines may still need to
be investigated further in depth. Bone loss was studied in the ligature model; however we
did not expect to see results due to the short duration of this model and potential inability
of the grape powder to elicit positive results in this short time period. Our results
reflected the same (data not shown). We might expect to see better results in future by
designing the experiment in a way as to pre-feed the mice with grape powder diet for a
period of 2 months before ligation and infection with P. gingivalis. Another way may be
to increase the dose of grape powder in the diet.
The Baker model was chosen to study bone loss since it a better representation of the
chronic nature of periodontitis and allows adequate time for colonization of bacteria.
Previous research has reported that grape seed pro-anthocyanidins contribute to bone
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homeostasis by increasing mandibular bone formation and bone strength (Kamitani, Maki
et al. 2004). Another study evaluated the effect of grape seed pro-anthocyanidins on
alveolar bone loss in mice and found reduced inflammation and bone loss via decreased
MMP-8 levels and increased osteoblastic activity (Toker, Balci Yuce et al. 2018). These
previous studies provided us a good rationale for investigating the effect of grape powder
on alveolar bone loss. Since the orally infected P. gingivalis equally colonizes the whole
oral cavity in a period of 2 months, we expected to see higher bone loss levels and thus
bone loss was measured at 14 predetermined sites. Buccal bone being thin and fenestrated
was chosen as ideal to study bone loss. Our data confirmed that grape powder had a
positive impact on alveolar bone as indicated by reduced CEJ-ABC distance and bone
loss levels (Fig 15).
Some researchers were particularly concerned about the detrimental effects of grape
components on RAW 264.7 cells. An experiment to assess the cytotoxicity of grape seed
pro-anthocyanidins was measured by MTT assay which concluded that RAW 264.7 cell
viability was not affected significantly by using concentrations up to 200 µg/ml (Chu,
Tang et al. 2016). This explains the basis for using the chosen concentrations of grape
powder extract in our research. An oral toxicity study of pro-anthocyanidins in the grape
skin and grape seed extract was conducted in mice over a three-month period, which
revealed no changes considered to be of toxicological significance (Bentivegna and
Whitney 2002). Thus, grape components may be developed as safe drugs for treatment of
periodontal disease.
The experimental findings in this research suggest that grape and its components could be
a promising natural agent for preventive and therapeutic treatment of periodontitis. Grape
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and grape components show great potential in periodontitis therapy on account of their
anti-bacterial, anti-inflammatory and anti-oxidative properties and ability to directly
inhibit osteoclastogenesis (Kempuraj, Madhappan et al. 2005). Our grape powder extract
is novel in the sense that this type of extract produced from whole grapes has not been
used in previous research. Grape powder extract has active and inactive components.
These components have been filtered according to their molecular weight fractions and
the most active components have been recognized. These are catechin, epicatechin,
quercetin, malvidin and peonidin. Future studies could be directed at testing the effects of
these specific active components on P. gingivalis growth, inflammation and bone loss. It
would be rewarding to find a single component exhibiting antibacterial properties
specific to P. gingivalis in conjunction with anti-inflammatory effects. The mechanism of
how our grape powder extract interacts with P. gingivalis still remains an area of
discussion. Grape components might possess antiadhesive properties which interfere with
the biofilm formation of P. gingivalis as previously seen with the ability of grape
components to inhibit biofilms of Streptococcus mutans (de la Iglesia, Milagro et al.
2010). Another study has also reported that pro-anthocyanidins from cranberries could
inhibit P. gingivalis biofilm formation (Labrecque, Bodet et al. 2006). We argued if the
mild acidic nature of grape powder extract was itself responsible for affecting P.
gingivalis growth. However, this seems unlikely since the acidity would have been
neutralized by the buffers present in the culture media. Another theory for this interaction
could be the presence of receptors on the surface of P. gingivalis which interact with
antibiotics in the grape components. One study by a group of researchers established that
black grape skin extract is rich in antimicrobial compounds which inhibit the growth of
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certain bacteria (Yadav, Kumar et al. 2015). This seems like a reasonable explanation for
our question.
It would seem beneficial to control periodontal inflammation by implementing
pharmacological adjuncts in addition to conventional mechanical therapy. One popular
approach for improving periodontal health is the use of therapeutic agents in oral hygiene
products (Ciancio 2011). Adding active components to toothpastes or mouthwashes may
enhance plaque removal. Grape power extract may be tested in dentifrices in this context.
Topical application may be another method to consider. Green tea catechin when applied
in the form of hydroxypropycellulose strips in the pockets of periodontal patients
exhibited an anti-bacterial affect against P. gingivalis and P. intermedia (Hirasawa,
Takada et al. 2002). It may be necessary to conduct further preclinical animal and human
trial studies as to gauge in what combinations and formulations these grape components
when used will be most effective in controlling periodontal inflammation (Palaska,
Papathanasiou et al. 2013). We can take our research a step further by experimenting with
human trial studies. One approach to testing the effect of grape powder extract in humans
would be to conduct experimental gingivitis studies with appropriate placebo controls.
The grape powder extract could be delivered in an injectable form or through a chewing
gum and the levels of inflammation and bacterial growth could be assessed after a certain
time period.
Oral diseases like caries and periodontal disease resulting in pain and tooth loss are one
of the commonly prevailing conditions that affect the American population (Bennadi and
Reddy 2013). These oral diseases not only impact systemic health but overall physical,
psychological, social, and economic well-being (Murthy 2016). Much recently, attention
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of researchers has been focused on identification of fruit components and development of
natural food products as “functional foods”. In spite of these advances, it seems that
people are still less aware of specific fruits that play a role in maintaining good oral
health and need to be brought to public attention. Naturally occurring active components
in fruits like grape have been shown to promote periodontal health. Our research
successfully attempted to investigate the grape in the context of causing good or harm to
periodontal health. We were able to establish that grape and its components were a safe
and natural means to control periodontal inflammation. Our research highlights that
grapes should be included as an important component of diet to promote oral health in a
natural way without any significant adverse effects. On the basis of this research and
further studies, we may find grape-derived compounds as alternatives or replacement to
the routinely used chemicals implicated in mechanical oral disease control in future. On
the basis of existing data, it is evident that grapes should be considered as an inherent
element of fruit-enriched diets that are encouraged strongly by health authorities
worldwide as a rewarding natural means to stay healthy and prevent disease. It is also
noteworthy that for the vast majority of people consuming grapes, allergy to this fruit is
hardly an issue (Pezzuto 2008). Also, who doesn’t like grapes?
In summary, our experimental results have successfully proven that grape components
are capable of inhibiting P. gingivalis growth, reducing pro-inflammatory cytokine
production, and RANKL-induced osteoclastogenesis. In addition, grape components are
able to reduce gingival inflammation and alveolar bone loss in murine models. On the
basis of these results, we can conclude that grape and grape components can indeed be
beneficial in the prevention and treatment of periodontal disease.
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